150 related articles for article (PubMed ID: 7589097)
21. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2.
Salvadori S; Zier K
J Immunol; 1996 Apr; 156(8):2927-32. PubMed ID: 8609413
[TBL] [Abstract][Full Text] [Related]
22. Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.
Gassmann M; Amrein KE; Flint NA; Schraven B; Burn P
Eur J Immunol; 1994 Jan; 24(1):139-44. PubMed ID: 7912674
[TBL] [Abstract][Full Text] [Related]
23. Induction of Fc epsilon RII/CD23 on PHA-activated human peripheral blood T lymphocytes and association of fyn tyrosine kinase with Fc epsilon RII/CD23.
Maekawa N; Kawabe T; Sugie K; Kawakami T; Maeda Y; Uchida A; Yodoi J
Int J Tissue React; 1992; 14(3):121-30. PubMed ID: 1446976
[TBL] [Abstract][Full Text] [Related]
24. Costimulation with dexamethasone and prostaglandin E2: a novel paradigm for the induction of T-cell anergy.
Elliott LH; Levay AK
Cell Immunol; 1997 Sep; 180(2):124-31. PubMed ID: 9341742
[TBL] [Abstract][Full Text] [Related]
25. CD28-induced cytokine production and proliferation by thymocytes are differentially regulated by the p59fyn tyrosine kinase.
Ong CJ; Lim AS; Teh HS
J Immunol; 1997 Sep; 159(5):2169-76. PubMed ID: 9278304
[TBL] [Abstract][Full Text] [Related]
26. Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein.
Wang J; Nemoto E; Dennert G
J Immunol; 1996 Apr; 156(8):2819-27. PubMed ID: 8609401
[TBL] [Abstract][Full Text] [Related]
27. Human airway epithelial cells stimulate T-lymphocyte lck and fyn tyrosine kinase.
Kalb TH; Yio XY; Mayer L
Am J Respir Cell Mol Biol; 1997 Nov; 17(5):561-70. PubMed ID: 9374107
[TBL] [Abstract][Full Text] [Related]
28. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn.
Quill H; Riley MP; Cho EA; Casnellie JE; Reed JC; Torigoe T
J Immunol; 1992 Nov; 149(9):2887-93. PubMed ID: 1357030
[TBL] [Abstract][Full Text] [Related]
29. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15.
Adunyah SE; Wheeler BJ; Cooper RS
Biochem Biophys Res Commun; 1997 Mar; 232(3):754-8. PubMed ID: 9126349
[TBL] [Abstract][Full Text] [Related]
31. Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20.
Deans JP; Kalt L; Ledbetter JA; Schieven GL; Bolen JB; Johnson P
J Biol Chem; 1995 Sep; 270(38):22632-8. PubMed ID: 7545683
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine protein kinases in T lymphocytes.
Peri KG; Veillette A
Chem Immunol; 1994; 59():19-39. PubMed ID: 7945927
[No Abstract] [Full Text] [Related]
33. Coordinate expression of src family protooncogenes in T cell activation and its modulation by cyclosporine.
Furue M; Katz SI; Kawakami Y; Kawakami T
J Immunol; 1990 Jan; 144(2):736-9. PubMed ID: 2104905
[TBL] [Abstract][Full Text] [Related]
34. Pervanadate simulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2.
Evans GA; Garcia GG; Erwin R; Howard OM; Farrar WL
J Biol Chem; 1994 Sep; 269(38):23407-12. PubMed ID: 8089104
[TBL] [Abstract][Full Text] [Related]
35. Control of T cell development by non-receptor protein tyrosine kinases.
Perlmutter RM
Cancer Surv; 1995; 22():85-95. PubMed ID: 7720061
[TBL] [Abstract][Full Text] [Related]
36. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase.
Fuertes MB; Molinero LL; Toscano MA; Ilarregui JM; Rubinstein N; Fainboim L; Zwirner NW; Rabinovich GA
Mol Cell Biochem; 2004 Dec; 267(1-2):177-85. PubMed ID: 15663199
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules.
Liu J; Finke J; Krauss JC; Shu S; Plautz GE
Cancer Immunol Immunother; 1998 Jul; 46(5):268-76. PubMed ID: 9690455
[TBL] [Abstract][Full Text] [Related]
38. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.
Kobayashi N; Kono T; Hatakeyama M; Minami Y; Miyazaki T; Perlmutter RM; Taniguchi T
Proc Natl Acad Sci U S A; 1993 May; 90(9):4201-5. PubMed ID: 8483935
[TBL] [Abstract][Full Text] [Related]
39. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity.
Dadi H; Ke S; Roifman CM
Blood; 1994 Sep; 84(5):1579-86. PubMed ID: 7520779
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of proliferative responses of human B cell precursor acute lymphoblastic leukemia (BCP-ALL) cells to interleukin 7 (IL-7): no correlation with immunoglobulin gene status and expression of IL-7 receptor or IL-2/IL-4/IL-7 receptor common gamma chain genes.
Smiers FJ; van Paassen M; Pouwels K; Beishuizen A; Hählen K; Löwenberg B; Touw IP
Leukemia; 1995 Jun; 9(6):1039-45. PubMed ID: 7596167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
